NEW YORK TIMES CO-A (NYT)

US6501111073 - Common Stock

53.25  +1.24 (+2.38%)

After market: 53.25 0 (0%)

Fundamental Rating

7

NYT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 92 industry peers in the Media industry. NYT gets an excellent profitability rating and is at the same time showing great financial health properties. NYT is quite expensive at the moment. It does show a decent growth rate.



8

1. Profitability

1.1 Basic Checks

NYT had positive earnings in the past year.
NYT had a positive operating cash flow in the past year.
Each year in the past 5 years NYT has been profitable.
Each year in the past 5 years NYT had a positive operating cash flow.

1.2 Ratios

With an excellent Return On Assets value of 10.14%, NYT belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
NYT's Return On Equity of 15.12% is amongst the best of the industry. NYT outperforms 83.52% of its industry peers.
With an excellent Return On Invested Capital value of 12.31%, NYT belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NYT is above the industry average of 7.61%.
The last Return On Invested Capital (12.31%) for NYT is above the 3 year average (10.37%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.14%
ROE 15.12%
ROIC 12.31%
ROA(3y)8%
ROA(5y)7.01%
ROE(3y)12.79%
ROE(5y)11.57%
ROIC(3y)10.37%
ROIC(5y)9.39%

1.3 Margins

NYT's Profit Margin of 11.04% is amongst the best of the industry. NYT outperforms 83.52% of its industry peers.
In the last couple of years the Profit Margin of NYT has grown nicely.
With a decent Operating Margin value of 14.00%, NYT is doing good in the industry, outperforming 76.92% of the companies in the same industry.
NYT's Operating Margin has improved in the last couple of years.
NYT has a Gross Margin of 49.02%. This is comparable to the rest of the industry: NYT outperforms 57.14% of its industry peers.
NYT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14%
PM (TTM) 11.04%
GM 49.02%
OM growth 3Y6.86%
OM growth 5Y2.17%
PM growth 3Y19.5%
PM growth 5Y5.91%
GM growth 3Y1.67%
GM growth 5Y-4.97%

9

2. Health

2.1 Basic Checks

NYT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
NYT has less shares outstanding than it did 1 year ago.
NYT has less shares outstanding than it did 5 years ago.
NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

NYT has an Altman-Z score of 8.18. This indicates that NYT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of NYT (8.18) is better than 94.51% of its industry peers.
NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.18
ROIC/WACC1.36
WACC9.05%

2.3 Liquidity

A Current Ratio of 1.35 indicates that NYT should not have too much problems paying its short term obligations.
NYT's Current ratio of 1.35 is in line compared to the rest of the industry. NYT outperforms 42.86% of its industry peers.
A Quick Ratio of 1.35 indicates that NYT should not have too much problems paying its short term obligations.
The Quick ratio of NYT (1.35) is comparable to the rest of the industry.
NYT does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35

4

3. Growth

3.1 Past

NYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.84%, which is quite impressive.
NYT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.15% yearly.
NYT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.86%.
NYT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.77% yearly.
EPS 1Y (TTM)24.84%
EPS 3Y19.13%
EPS 5Y15.15%
EPS Q2Q%21.62%
Revenue 1Y (TTM)-14.86%
Revenue growth 3Y10.8%
Revenue growth 5Y6.77%
Sales Q2Q%6.99%

3.2 Future

The Earnings Per Share is expected to grow by 9.74% on average over the next years. This is quite good.
NYT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.94% yearly.
EPS Next Y19.48%
EPS Next 2Y13%
EPS Next 3Y12.4%
EPS Next 5Y9.74%
Revenue Next Year6.44%
Revenue Next 2Y6.51%
Revenue Next 3Y6.26%
Revenue Next 5Y4.94%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.88, the valuation of NYT can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as NYT.
Compared to an average S&P500 Price/Earnings ratio of 28.96, NYT is valued at the same level.
With a Price/Forward Earnings ratio of 25.43, NYT can be considered very expensive at the moment.
NYT's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.82. NYT is around the same levels.
Industry RankSector Rank
PE 27.88
Fwd PE 25.43

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NYT is on the same level as its industry peers.
NYT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 23.72
EV/EBITDA 17.65

4.3 Compensation for Growth

NYT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
NYT has an outstanding profitability rating, which may justify a higher PE ratio.
NYT's earnings are expected to grow with 12.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.43
PEG (5Y)1.84
EPS Next 2Y13%
EPS Next 3Y12.4%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.96%, NYT is not a good candidate for dividend investing.
NYT's Dividend Yield is a higher than the industry average which is at 3.98.
Compared to an average S&P500 Dividend Yield of 2.23, NYT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.96%

5.2 History

On average, the dividend of NYT grows each year by 21.18%, which is quite nice.
NYT has paid a dividend for at least 10 years, which is a reliable track record.
NYT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)21.18%
Div Incr Years5
Div Non Decr Years10

5.3 Sustainability

NYT pays out 28.43% of its income as dividend. This is a sustainable payout ratio.
NYT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.43%
EPS Next 2Y13%
EPS Next 3Y12.4%

NEW YORK TIMES CO-A

NYSE:NYT (11/21/2024, 8:04:00 PM)

After market: 53.25 0 (0%)

53.25

+1.24 (+2.38%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.73B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.96%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 27.88
Fwd PE 25.43
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.43
PEG (5Y)1.84
Profitability
Industry RankSector Rank
ROA 10.14%
ROE 15.12%
ROCE
ROIC
ROICexc
ROICexgc
OM 14%
PM (TTM) 11.04%
GM 49.02%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)24.84%
EPS 3Y19.13%
EPS 5Y
EPS Q2Q%
EPS Next Y19.48%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-14.86%
Revenue growth 3Y10.8%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y